1. Cell division cycle associated 1 as a novel prognostic biomarker and therapeutic target for oral cancer
   Phung Manh Thang et al, 2016 CrossRef
2. pH low insertion peptide mediated cell division cycle-associated protein 1 -siRNA transportation for prostatic cancer therapy targeted to the tumor microenvironment
   Zhining Zhao et al, 2018, Biochemical and Biophysical Research Communications CrossRef
3. Comprehensive assessment of cancer missense mutation clustering in protein structures
   Atanas Kamburov et al, 2015, Proc Natl Acad Sci USA CrossRef
4. Screening key lncRNAs for human rectal adenocarcinoma based on lncRNA‐mRNA functional synergistic network
   Xiongwen Zhu et al, 2019, Cancer Med CrossRef
5. siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferationin vitroandin vivo
   Peng Hu et al, 2015, Biosci. Rep. CrossRef
6. Heterogeneous nuclear ribonucleoprotein K upregulates the kinetochore complex component NUF2 and promotes the tumorigenicity of colon cancer cells
   Hironobu Sugimasa et al, 2015, Biochemical and Biophysical Research Communications CrossRef
7. Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma
   Haiping Zhang et al, 2019 CrossRef
8. Analysis of the Expression of Cell Division Cycle-Associated Genes and Its Prognostic Significance in Human Lung Carcinoma: A Review of the Literature Databases.
   Chongxiang Chen et al, 2020, Biomed Res Int CrossRef
9. Characterization of KIF20A as a prognostic biomarker and therapeutic target for different subtypes of breast cancer
   Masako Nakamura et al, 2020, Int J Oncol CrossRef
10. Characterization of KIF11 as a novel prognostic biomarker and therapeutic target for oral cancer
    Kayo Daigo et al, 2017, Int J Oncol CrossRef
11. Weighted gene co‑expression network analysis for identifying hub genes in association with prognosis in Wilms tumor
    Xiaofu Wang et al, 2019, Mol Med Report CrossRef
12. Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer.
    Xiuming Zhai et al, 2020, PeerJ CrossRef
13. Prognostic impact of LY6K and CDCA1 expression for patients with esophageal squamous cell carcinoma
    Junya Oguma et al, 2020, Ann Gastroenterol Surg CrossRef
14. A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cells
    Muhammad Sohail et al, 2021 CrossRef
15. MicroRNA-34c-5p Inhibition of NUF2 Suppresses Lung Adenocarcinoma Cell Viability and Invasion
    Xiaoguang You et al, 2021, Journal of Nanomaterials CrossRef
16. Regulators CDCA8 as potential targets and biomarkers for the prognosis of human skin cutaneous melanoma
    Rong Guo et al, 2022, J of Cosmetic Dermatology CrossRef
17. FOXM1 Promotes Tumor Progression by Targeting CDCA5 in Adrenocortical Carcinoma
    Shengzhuo Liu et al, 2021, SSRN Journal CrossRef
18. NUF2 Expression in Cancer Tissues and Lymph Nodes Suggests Post-Surgery Recurrence of Non-Small Cell Lung Cancer
    Chika Shirakami et al, 2024, Diagnostics CrossRef
19. Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer
    Regina Mbugua et al, 2024, Int J Oncol CrossRef